Literature DB >> 10820397

Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice.

L Camoglio1, A A te Velde, A de Boer, F J ten Kate, M Kopf, S J van Deventer.   

Abstract

IFN-gamma is a potent pro-inflammatory cytokine thought to be involved in the pathogenesis of Crohn's disease. To further define the role of IFN-gamma in intestinal inflammation, we studied the effects of intra-colonic 2,4,6-trinitrobenzene sulfonic acid (TNBS) instillation in mice with a functionally inactivated IFN-gamma receptor 1 (IFN-gammaR1(- / -)). Our results indicate that IFN-gamma is not necessary for the induction of hapten-induced colitis: after TNBS administration both wild-type and IFN-gammaR1(- / -) mice lost body weight, and the histological features of TNBS-induced colitis were comparable. Colons of IFN-gammaR1(- / -) mice contained a greater number of cells, represented by macrophages and CD4(+) T cells; caudal lymph node cells produced more IFN-gamma and TNF-alpha upon stimulation in vitro. Moreover, IL-18 and IL-12 p40 RNA levels were comparably up-regulated after TNBS treatment in IFN-gammaR1(- / -) wild-type mice. These findings demonstrate that IFN-gamma is dispensable for the development of TNBS-induced colitis. Importantly, the production of Th1 cytokines (e. g. IFN-gamma and TNF-alpha) by caudal lymph node T lymphocytes was enhanced rather than decreased in IFNgammaR1(- / -) mice with no evidence for default Th2 development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820397     DOI: 10.1002/(SICI)1521-4141(200005)30:5<1486::AID-IMMU1486>3.0.CO;2-8

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

Review 1.  Averting inflammation by targeting the cytokine environment.

Authors:  Manfred Kopf; Martin F Bachmann; Benjamin J Marsland
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 2.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

3.  Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility.

Authors:  Simon P Hogan; Luqman Seidu; Carine Blanchard; Katherine Groschwitz; Anil Mishra; Margaret L Karow; Richard Ahrens; David Artis; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2006-07       Impact factor: 10.793

4.  Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.

Authors:  T ten Hove; B van den Blink; I Pronk; P Drillenburg; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

5.  Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.

Authors:  M C Kullberg; A G Rothfuchs; D Jankovic; P Caspar; T A Wynn; P L Gorelick; A W Cheever; A Sher
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Activation of nuclear factor-kappa B and effects of pyrrolidine dithiocarbamate on TNBS-induced rat colitis.

Authors:  Ken Chen; You-Ming Long; Hui Wang; Lei Lan; Zhen-He Lin
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

7.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 8.  Parasitic helminths: new weapons against immunological disorders.

Authors:  Yoshio Osada; Tamotsu Kanazawa
Journal:  J Biomed Biotechnol       Date:  2010-02-10

9.  Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulation.

Authors:  Fernando Magro; Sónia Fraga; Tomé Ribeiro; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

10.  A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells.

Authors:  Genevieve Fortin; Marianne Raymond; Vu Quang Van; Manuel Rubio; Patrick Gautier; Marika Sarfati; Denis Franchimont
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.